GAM
TXMD icon

Gotham Asset Management’s TherapeuticsMD TXMD Stock Holding History

Gotham Asset Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-224
Closed -$14K – 1095
2020
Q4 		$14K Sell
224
-241
-52% -$16.5K ﹤0.01% 984
2020
Q3 		$37K Buy
+465
New +$37.1K ﹤0.01% 1005
2020
Q1 		– Sell
-305
Closed -$37K – 1212
2019
Q4 		$37K Sell
305
-202
-40% -$29K ﹤0.01% 1084
2019
Q3 		$92K Buy
+507
New +$71.5K ﹤0.01% 1056

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gotham Asset Management's TXMD Position: Q1 2021 in Review

Gotham Asset Management sold out of TherapeuticsMD (TXMD) in Q1 2021, closing a stake of 224 shares — an estimated $14K sold.

Gotham Asset Management first reported a position in TXMD in Q3 2019 and held it in 4 quarters. The position peaked at $92K in Q3 2019. 160 funds tracked by Wall St. Rank hold TXMD as of Q1 2021.

  • Gotham Asset Management reported no remaining TherapeuticsMD position as of Q1 2021 after selling out during the quarter.
  • Gotham Asset Management sold 224 TherapeuticsMD shares in Q1 2021, an estimated $14K.
  • Gotham Asset Management first reported a position in TherapeuticsMD in Q3 2019 and held it in 4 quarters.
  • Gotham Asset Management's TherapeuticsMD position peaked at $92K in Q3 2019.
  • 160 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2021.

Based on Gotham Asset Management's 13F filing for Q1 2021, filed 17 May 2021.